Mikael Dolsten Net Worth & Insider Trades

Mikael Dolsten - President R&D, Pfizer Inc

As of November 9, 2022

What is Mikael Dolsten's Net Worth?

The current estimated net worth of Pfizer Inc's President R&D, Mikael Dolsten, is estimated to be about $4.75B . Mikael Dolsten owns about 335,159 units of Pfizer Inc common stock. In the last 13 years at Pfizer Inc, Mikael Dolsten has sold an estimated value of $71.81M worth.

What is Mikael Dolsten's Past Insider Trading?

Mikael Dolsten's largest purchase order was 199,548 units , worth over $5.01M on November 15, 2021. Mikael Dolsten's largest sale order was 149,553 units , worth over $6.51M on March 5, 2019. In total, Mikael Dolsten has made about 86 transactions over 13 years of their time at Pfizer Inc. Mikael Dolsten usually trades in March, with the busiest year in 2013. The most recent transaction was a sale order of 63,902 units , worth over $3.15M on May 12, 2022.

Mikael Dolsten

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What was Mikael Dolsten's Salary in 2020?

As President R&D of Pfizer Inc, Mikael Dolsten has a total base salary of $1,433,750 . Mikael Dolsten received compensation valued at about $10,149,624 in 2020 after becoming President R&D. The vast majority of their compensation came in the form of stock awards of $2,110,585 , option awards of $2,608,832 , other earnings, plans or compensations of $2,600,000 , change in pension value of $928,638 , and other compensation of $467,819 .

What is Mikael Dolsten's' Mailing Address?

  • Mailing address is 5 Giralda Farms Madison NJ 07940 NJ

Pfizer Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Change in Pension Value
Other Compensation
Total
A. Bourla 2020 $1,650,000 - $4,897,817 $6,782,951 $5,491,800 $1,367,780 $843,222 $21,033,570
A. Bourla 2019 $1,600,000 - $4,290,956 $6,075,290 $3,630,000 $1,726,448 $606,269 $17,928,963
A. Bourla 2018 $1,400,000 - $2,592,079 $3,954,369 $1,533,000 $0 $375,109 $9,854,557
F. D’Amelio 2020 $1,533,750 - $2,406,437 $3,130,596 $2,470,000 $1,318,297 $517,016 $11,376,096
F. D’Amelio 2019 $1,500,000 - $2,582,446 $3,037,649 $1,820,000 $1,612,163 $523,472 $11,075,730
F. D’Amelio 2018 $1,407,917 - $2,013,091 $2,108,995 $1,310,000 $0 $299,826 $7,139,829
M. Dolsten 2020 $1,433,750 - $2,110,585 $2,608,832 $2,600,000 $928,638 $467,819 $10,149,624
M. Dolsten 2019 $1,400,000 - $2,414,725 $2,531,376 $1,820,000 $987,243 $444,701 $9,598,045
M. Dolsten 2018 $1,306,250 - $2,013,091 $2,108,995 $1,326,000 $0 $315,863 $7,070,199
A. Hwang 2020 $1,142,500 - $1,420,129 $2,087,062 $2,387,800 $405,242 $440,714 $7,883,447
J. Young 2020 $1,285,000 - $1,814,734 $2,087,062 $1,800,000 $1,551,403 $450,994 $8,989,193
J. Young 2019 $1,245,000 - $2,247,004 $2,025,093 $1,675,000 $1,325,847 $441,439 $8,959,383
J. Young 2018 $1,206,250 - $2,013,091 $2,108,995 $1,385,000 $0 $408,379 $7,121,715
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/78003/000007800321000047/proxystatement.htm

What are Pfizer Inc's Past Insider Trades?

Pfizer Inc's most recent insider trade came on June 8, 2022 by Jennifer B Damico who sold 4,218 units worth $227.6K . In the last 19 years, insiders at Pfizer Inc have sold an estimated value of $956.55M and bought an estimated value of $481.66M worth of shares. Insider trading is most common in April, with the busiest year in 2013. The most active traders at the company are Loretta V Cangialosi, Sr. Vice President,  Albert Bourla, Chairman & CEO,  and Rady A Johnson, Executive Vice President .

PFIZER INC Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1